Alliance transfers IP (intellectual property) to Metracor for equity stake
This article was originally published in Clinica
Executive Summary
Alliance Pharmaceuticals has gained an ownership position in Metracor Technologies, a San Diego, California-based device company developing a real-time cardiovascular and oxygenation monitoring device.